Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM)

European Journal of Medicinal Chemistry

Volumn 61, Issue , 2013, Pages 73-83

  Yan, Aixia ^a   Nie, Xianglei ^a   Wang, Kai ^a   Wang, Maolin ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Aurora kinase inhibitors; Classification models; Extended connectivity fingerprints (ECFP 4); Self organizing map (SOM); Support vector machine (SVM)

Indexed keywords

AURORA A KINASE; AURORA B KINASE; AURORA KINASE INHIBITOR;

ACCURACY; ARTICLE; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG SELECTIVITY; EXTENDED CONNECTIVITY FINGERPRINT; PREDICTION; SELF ORGANIZING MAP; STRUCTURE ACTIVITY RELATION; SUPPORT VECTOR MACHINE;

AURORA KINASES; MOLECULAR STRUCTURE; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT VECTOR MACHINES;

EID: 84874936626     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.06.037     Document Type: Article

References (62)

1. G. Mountzios, E. Terpos, and M.A. Dimopoulos Aurora kinases as targets for cancer therapy Cancer Treat Rev. 34 2008 175 182
2. H. Katayama, and S. Sen Aurora kinase inhibitors as anticancer molecules Biochim. Biophys. Acta 1799 2010 829 839
3. M. Carmena, and W.C. Earnshaw The cellular geography of aurora kinases Nat. Rev. Mol. Cell Bio. 4 2003 842 854
4. A. Yan, L. Wang, S. Xu, and J. Xu Aurora-A kinase inhibitor scaffolds and binding modes, Drug Discov Today 16 2011 260 269
5. M. Carmena, S. Ruchaud, and W.C. Earnshaw Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins Curr. Opin. Cell Biol. 21 2009 796 805
6. G. Vader, and S.M. Lens The Aurora kinase family in cell division and cancer, Biochim. Biophys Acta 1786 2008 60 72
7. H. Katayama, W.R. Brinkley, and S. Sen The Aurora kinases: role in cell transformation and tumorigenesis Cancer Metastasis Rev. 22 2003 451 464
8. N. Keen, and S. Taylor Aurora-kinase inhibitors as anticancer agents Nat. Rev. Cancer 4 2004 927 936
9. J.R. Pollard, and M. Mortimore Discovery and development of aurora kinase inhibitors as anticancer agents J. Med. Chem. 52 2009 2629 2651
10. N.D. Adams, J.L. Adams, J.L. Burgess, A.M. Chaudhari, R.A. Copeland, C.A. Donatelli, D.H. Drewry, K.E. Fisher, T. Hamajima, M.A. Hardwicke, W.F. Huffman, K.K. Koretke-Brown, Z.V. Lai, O.B. McDonald, H. Nakamura, K.A. Newlander, C.A. Oleykowski, C.A. Parrish, D.R. Patrick, R. Plant, M.A. Sarpong, K. Sasaki, S.J. Schmidt, D.J. Silva, D. Sutton, J. Tang, C.S. Thompson, P.J. Tummino, J.C. Wang, H. Xiang, J. Yang, and D. Dhanak Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase J. Med. Chem. 53 2010 3973 4001
11. K. Sasai, H. Katayama, D.L. Stenoien, S. Fujii, R. Honda, M. Kimura, Y. Okano, M. Tatsuka, F. Suzuki, E.A. Nigg, W.C. Earnshaw, W.R. Brinkley, and S. Sen Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells Cytoskeleton 59 2004 249 263
12. S. Sakkiah, S. Thangapandian, S. John, and K.W. Lee Identification of critical chemical features for Aurora kinase-B inhibitors using Hip-Hop, virtual screening and molecular docking J. Mol. Struct. 985 2011 14 26
13. L. Wang, Z. Wang, A. Yan, and Q. Yuan Classification of Aurora-A Kinase Inhibitors Using Self-Organizing Map (SOM) and Support Vector Machine (SVM) Mol. Inf. 30 2011 35 44
14. A. Yan, Y. Chong, L. Wang, X. Hu, and K. Wang Prediction of biological activity of Aurora-A kinase inhibitors by multilinear regression analysis and support vector machine Bioorg. Med. Chem. Lett. 21 2011 2238 2243
15. T. Liu, Y. Lin, X. Wen, R.N. Jorissen, and M.K. Gilson BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities Nucleic Acids Res. 35 2007 198 201
16. M. Zhong, M. Bui, W. Shen, S. Baskaran, D.A. Allen, R.A. Elling, W.M. Flanagan, A.D. Fung, E.J. Hanan, S.O. Harris, S.A. Heumann, U. Hoch, S.N. Ivy, J.W. Jacobs, S. Lam, H. Lee, R.S. McDowell, J.D. Oslob, H.E. Purkey, M.J. Romanowski, J.A. Silverman, B.T. Tangonan, P. Taverna, W. Yang, J.C. Yoburn, C.H. Yu, K.M. Zimmerman, T. O'Brien, and W. Lew 2-Aminobenzimidazoles as potent Aurora kinase inhibitors Bioorg. Med. Chem. Lett. 19 2009 5158 5161
17. A.D. Kerekes, S.J. Esposite, R.J. Doll, J.R. Tagat, T. Yu, Y. Xiao, Y. Zhang, D.B. Prelusky, S. Tevar, K. Gray, G.A. Terracina, S. Lee, J. Jones, M. Liu, A.D. Basso, and E.B. Smith Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure J. Med. Chem. 54 2011 201 210
18. I. Aliagas-Martin, D. Burdick, L. Corson, J. Dotson, J. Drummond, C. Fields, O.W. Huang, T. Hunsaker, T. Kleinheinz, E. Krueger, J. Liang, J. Moffat, G. Phillips, R. Pulk, T.E. Rawson, M. Ultsch, L. Walker, C. Wiesmann, B. Zhang, B.Y. Zhu, and A.G. Cochran A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B J. Med. Chem. 52 2009 3300 3307
19. T. Sardon, T. Cottin, J. Xu, A. Giannis, and I. Vernos Development and biological evaluation of a novel aurora A kinase inhibitor Chembiochem 10 2009 464 478
20. J.D. Oslob, M.J. Romanowski, D.A. Allen, S. Baskaran, M. Bui, R.A. Elling, W.M. Flanagan, A.D. Fung, E.J. Hanan, S. Harris, S.A. Heumann, U. Hoch, J.W. Jacobs, J. Lam, C.E. Lawrence, R.S. McDowell, M.A. Nannini, W. Shen, J.A. Silverman, M.M. Sopko, B.T. Tangonan, J. Teague, J.C. Yoburn, C.H. Yu, M. Zhong, K.M. Zimmerman, T. O'Brien, and W. Lew Discovery of a potent and selective aurora kinase inhibitor Bioorg. Med. Chem. Lett. 18 2008 4880 4884
21. D.B. Belanger, P.J. Curran, A. Hruza, J. Voigt, Z. Meng, A.K. Mandal, M.A. Siddiqui, A.D. Basso, and K. Gray Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors Bioorg. Med. Chem. Lett. 20 2010 5170 5174
22. C.C. Chiang, Y.H. Lin, S.F. Lin, C.L. Lai, C. Liu, W.Y. Wei, S.C. Yang, R.W. Wang, L.W. Teng, S.H. Chuang, J.M. Chang, T.T. Yuan, Y.S. Lee, P. Chen, W.K. Chi, J.Y. Yang, H.J. Huang, C.B. Liao, and J.J. Huang Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile J. Med. Chem. 53 2010 5929 5941
23. Y. Shiotsu, H. Kiyoi, Y. Ishikawa, R. Tanizaki, M. Shimizu, H. Umehara, K. Ishii, Y. Mori, K. Ozeki, Y. Minami, A. Abe, H. Maeda, T. Akiyama, Y. Kanda, Y. Sato, S. Akinaga, and T. Naoe KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation Blood 114 2009 1607 1617
24. T.E. Rawson, M. Ruth, E. Blackwood, D. Burdick, L. Corson, J. Dotson, J. Drummond, C. Fields, G.J. Georges, B. Goller, J. Halladay, T. Hunsaker, T. Kleinheinz, H.W. Krell, J. Li, J. Liang, A. Limberg, A. McNutt, J. Moffat, G. Phillips, Y. Ran, B. Safina, M. Ultsch, L. Walker, C. Wiesmann, B. Zhang, A. Zhou, B.Y. Zhu, P. Ruger, and A.G. Cochran A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability J. Med. Chem. 51 2008 4465 4475
25. J.P. Jani, J. Arcari, V. Bernardo, S.K. Bhattacharya, D. Briere, B.D. Cohen, K. Coleman, J.G. Christensen, E.O. Emerson, A. Jakowski, K. Hook, G. Los, J.D. Moyer, I. Pruimboom-Brees, L. Pustilnik, A.M. Rossi, S.J. Steyn, C. Su, K. Tsaparikos, D. Wishka, K. Yoon, and J.L. Jakubczak PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy Mol. Cancer Ther. 9 2010 883 894
26. M.E. Prime, S.M. Courtney, F.A. Brookfield, R.W. Marston, V. Walker, J. Warne, A.E. Boyd, N.A. Kairies, W. von der Saal, A. Limberg, G. Georges, R.A. Engh, B. Goller, P. Rueger, and M. Rueth Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinase J. Med. Chem. 54 2011 312 319
27. S. Blanchard, A.D. William, A.C. Lee, A. Poulsen, E.L. Teo, W. Deng, N. Tu, E. Tan, K.L. Goh, W.C. Ong, C.P. Ng, K.C. Goh, Z. Bonday, and E.T. Sun Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitors Bioorg. Med. Chem. Lett. 20 2010 2443 2447
28. S. Howard, V. Berdini, J.A. Boulstridge, M.G. Carr, D.M. Cross, J. Curry, L.A. Devine, T.R. Early, L. Fazal, A.L. Gill, M. Heathcote, S. Maman, J.E. Matthews, R.L. McMenamin, E.F. Navarro, M.A. O'Brien, M. O'Reilly, D.C. Rees, M. Reule, D. Tisi, G. Williams, M. Vinkovic, and P.G. Wyatt Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity† J. Med. Chem. 52 2008 379 388
29. S. Tasler, O. Muller, T. Wieber, T. Herz, S. Pegoraro, W. Saeb, M. Lang, R. Krauss, F. Totzke, U. Zirrgiebel, J.E. Ehlert, M.H. Kubbutat, and C. Schachtele Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization Bioorg. Med. Chem. 17 2009 6728 6737
30. V. Myrianthopoulos, P. Magiatis, Y. Ferandin, A.L. Skaltsounis, L. Meijer, and E. Mikros An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins J. Med. Chem. 50 2007 4027 4037
31. R.M. Angell, R.A. Harris, R. Kelsey, J. Lumley, and A. Slatter Preparation of 2,4-diaminopyrimidine derivatives useful as inhibitors of Aurora kinase, in: (Arrow Therapeutics Limited, UK). WO 2009 pp. 59
32. D. Fancelli, M. Pulici, G. Cervi, F. Quartieri, and P. Vianello 1H-Furo[3,2-C]Pyrazoles active as aurora kinase inhibitors, in: (Nerviano Medical Sciences S.r.l., Italy). EP 2009 pp. 41
33. V.J. Cee, H.N. Nguyen, and K. Romero Preparation of substituted phthalazinamines as Aurora kinase modulators, in: (Amgen Inc., USA). U.S. 2009 pp. 74pp; Chemical Indexing Equivalent to 147:235186 (WO)
34. L. Zhuang, D.A. Claremon, S.B. Singh, L. Shen, Y. Zheng, and J.D. Lawson Preparation of quinazolinylaminopyrazolylacetamides as Aurora kinase inhibitors, in: (Vitae Pharmaceuticals, Inc., USA). WO 2009 pp. 100
35. N. Aurrecoechea, P.P. Beroza, K.V. Damodaran, K.Y. Pontius, L. Robinson, R.J. Simon, T. Vu, and K.T. Weber 2-[1H-benzimidazol-2(3H)-ylidene]-2- (pyrimidin-2-yl) acetamides and 2-[benzotiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl) acetamides as kinase inhibitors, in, Telik, Inc., EP 2011
36. Y. Luo, and F. Shu Kinase inhibitors and their use as pharmaceutical agents, Shanghai genomics, INC., WO 2010
37. J. Zhu, L. Wang, and A. Yan Classification of Aurora Kinase inhibitors by Self-Organizing Map and Support Vector Machine X. Zhou, The 1st International Conference on Cellular, Molecular Biology, Biophysics and Bioengineering (CMBB 2010) 2010 International Science and Engineering Center Hong Kong, Qiqihar, China 525 530
38. MOE (The Molecular Operating Environment) version 2010 2010 Chemical Computing Group Inc Montreal, Canada
39. L. Lin, and G. Lin The Progress of Aurora Kinase and Its Inhibitors Strait Pharmaceutical Journal 22 2010
40. SONNIA can be obtained from Molecular Networks GmbH, Erlangen, Germany. < http://www.molecular-networks.com > (accessed Apr 2012).
41. ADRIANA.Code, Molecular Networks GmbH, Erlangen, Germany. < http://www.molecular-networks.com > (accessed Apr 2012).
42. P. Ertl, B. Rohde, and P. Selzer Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties J. Med. Chem. 43 2000 3714 3717
43. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3 26
44. K.J. Miller Additivity methods in molecular polarizability J. Am. Chem. Soc. 112 1990 8533 8542
45. M. Petitjean Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds J. Chem. Inf. Model. 32 1992 331 337
46. M.V. Volkenstein The configurational statistics of polymeric chains J. Polym. Sci. 29 1958 441 454
47. C. Tanford Physical chemistry of macromolecules first ed. 1961 Interscience Publishers, Inc. New York
48. G.B. Moreau, and Pierre The autocorrelation of a topological structure: a new molecular descriptor Nouv. J. Chim. 4 1980 359 360
49. M. Wagener, J. Sadowski, and J. Gasteiger Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks J. Am. Chem. Soc. 117 1995 7769 7775
50. J. Gasteiger, and M. Marsili A New Method for Calculating Atomic Charges in Molecules Tetrahedron Lett. 34 1978 3181 3184
51. J. Gasteiger Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges Tetrahedron 36 1980 3219 3228
52. J. Gasteiger, and M.G. Hutchings Quantitative models of gas-phase proton-transfer reactions involving alcohols, ethers, and their thio analogs. Correlation analyses based on residual electronegativity and effective polarizability J. Am. Chem. Soc. 106 1984 6489 6495
53. A. Teckentrup, H. Briem, and J. Gasteiger Mining high-throughput screening data of combinatorial libraries: development of a filter to distinguish hits from nonhits J. Chem. Inf. Comput. Sci. 44 2004 626 634
54. H.L. Morgan The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service J. Chem. Doc. 5 1965 107 113
55. A. Bender, J.L. Jenkins, J. Scheiber, S.C. Sukuru, M. Glick, and J.W. Davies How similar are similarity searching methods? A principal component analysis of molecular descriptor space J Chem Inf Model 49 2009 108 119
56. T. Kohonen Self-organized formation of topologically correct feature maps Neurocomputing: foundations of research 1988 MIT Press 509 521
57. T. Kohonen Self-Organization and Associative Memory third ed. 1989 Springer Berlin
58. LIBSVM: a library for support vector machine Software available at: http://www.csie.ntu.edu.tw/∼cjlin/libsvm 2012
59. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 45 2002 2615 2623
60. R. Todeschini, V. Consonni, R. Mannhold, H. Kubinyi, and H. Timmerman Handbook of Molecular Descriptors 2008 John Wiley & Sons
61. N. Mahobia, K, R. Patel, D, N. Sheikh, W, S. Singh, K, A. Mishra, and R. Dhardubey Validation Method Used In Quantitative Structure Activity Relationship Der Pharma Chemica 2 2010 260 271
62. L.K. Dow, S. Kalelkar, and E.R. Dow Self-organizing maps for the analysis of NMR spectra, Drug Discov Today: Biosilico 2 2004 157 163